rs141536395

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014254.3(RXYLT1):​c.1226A>G​(p.Glu409Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,612,494 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 9 hom. )

Consequence

RXYLT1
NM_014254.3 missense

Scores

1
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 7.28

Publications

2 publications found
Variant links:
Genes affected
RXYLT1 (HGNC:13530): (ribitol xylosyltransferase 1) This gene encodes a type II transmembrane protein that is thought to have glycosyltransferase function. Mutations in this gene result in cobblestone lissencephaly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
RXYLT1-AS1 (HGNC:48910): (RXYLT1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005658388).
BP6
Variant 12-63808986-A-G is Benign according to our data. Variant chr12-63808986-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00603 (918/152364) while in subpopulation AFR AF = 0.0211 (879/41580). AF 95% confidence interval is 0.02. There are 9 homozygotes in GnomAd4. There are 475 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RXYLT1NM_014254.3 linkc.1226A>G p.Glu409Gly missense_variant Exon 6 of 6 ENST00000261234.11 NP_055069.1 Q9Y2B1
RXYLT1NM_001278237.2 linkc.446A>G p.Glu149Gly missense_variant Exon 6 of 6 NP_001265166.1 Q9Y2B1
RXYLT1XM_047428078.1 linkc.917A>G p.Glu306Gly missense_variant Exon 5 of 5 XP_047284034.1
RXYLT1-AS1NR_126167.1 linkn.468-46T>C intron_variant Intron 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RXYLT1ENST00000261234.11 linkc.1226A>G p.Glu409Gly missense_variant Exon 6 of 6 1 NM_014254.3 ENSP00000261234.6 Q9Y2B1

Frequencies

GnomAD3 genomes
AF:
0.00603
AC:
918
AN:
152246
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0212
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00140
AC:
348
AN:
248824
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.0201
Gnomad AMR exome
AF:
0.000932
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000888
Gnomad OTH exome
AF:
0.000663
GnomAD4 exome
AF:
0.000525
AC:
767
AN:
1460130
Hom.:
9
Cov.:
30
AF XY:
0.000434
AC XY:
315
AN XY:
726418
show subpopulations
African (AFR)
AF:
0.0194
AC:
646
AN:
33294
American (AMR)
AF:
0.00126
AC:
56
AN:
44452
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000466
AC:
4
AN:
85834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53386
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1111276
Other (OTH)
AF:
0.000879
AC:
53
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00603
AC:
918
AN:
152364
Hom.:
9
Cov.:
32
AF XY:
0.00638
AC XY:
475
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.0211
AC:
879
AN:
41580
American (AMR)
AF:
0.00183
AC:
28
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68044
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
48
95
143
190
238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00198
Hom.:
7
Bravo
AF:
0.00716
ESP6500AA
AF:
0.0164
AC:
72
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00186
AC:
226
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 02, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10 Benign:1
Apr 20, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.10
T;.
Eigen
Benign
-0.034
Eigen_PC
Benign
0.16
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.78
T;T
MetaRNN
Benign
0.0057
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
7.3
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-3.2
D;D
REVEL
Benign
0.091
Sift
Benign
0.15
T;T
Sift4G
Benign
0.24
T;T
Polyphen
0.066
B;B
Vest4
0.15
MVP
0.10
MPC
0.21
ClinPred
0.030
T
GERP RS
5.0
Varity_R
0.14
gMVP
0.42
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141536395; hg19: chr12-64202766; COSMIC: COSV107198717; COSMIC: COSV107198717; API